Suit Accuses Generic Drugmakers Of Overcharging Medicaid

The Associated Press/CBS News: Whistleblower Lawsuit Accuses Generic Drugmakers Of Scheme That Overcharged Medicaid
Three generic drugmakers are being accused in a whistleblower lawsuit of scheming to overcharge the government by tens of millions of dollars for medicines. The U.S. Attorney's office on Tuesday joined in the lawsuit, brought by Chicago pharmacist Bernard Lisitza. His attorneys alleged in a 162-page complaint unsealed Tuesday afternoon that Par Pharmaceuticals Companies Inc. of Woodcliff Lake, N.J., and two foreign generic drugmakers overcharged the Medicaid program by getting pharmacies to dispense different, more-expensive, dosage forms than what was prescribed. ... All three companies have denied wrongdoing (Johnson, 9/6).

This is part of Kaiser Health News' Daily Report - a summary of health policy coverage from major news organizations. The full summary of the day's news can be found here and you can sign up for e-mail subscriptions to the Daily Report here. In addition, our staff of reporters and correspondents file original stories each day, which you can find on our home page.